References
- AbramsonJStarfieldB2005The effect of conflict of interest on biomedical research and clinical practice guidelines: Can we trust the evidence in evidence-based medicine?JABFP184141816148253
- BekelmanJELiYGrossCP2003Scope and impact of financial conflicts of interest in biomedical researchJAMA2894546512533125
- Canadian Coordinating Office for Health Technology Assessment2005CEDAC final recommendation on reconsideration and reasons for recommendationInsulin glargine (Lantus® – Aventis Pharma Inc.) [online]Accessed November 24, 2005 URL: http://www.ccohta.ca/CDR/cdr_pdf/cdr_submissions/Complete/cdr_complete_Lantus_2005Sept28.pdf
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Canadian Diabetes Association2003Clinical practice guidelines for the prevention and management of diabetes in CanadaCan J Diabetes27suppl 2S1S152
- ChoudhryNKStelfoxHTDetskyAS2002Relationships between authors of clinical practice guidelines and the pharmaceutical industryJAMA2876121711829700
- Editorial2005Clinical practice guidelines and conflicts of interestCMAJ173129716301688
- JonesJHunterD1995Qualitative research: Consensus methods for medical and health services researchBMJ311376807640549
- KerridgeIMaguireDNewbyD2005Cooperative partnerships or conflicts-of interest? A national survey of interaction between the pharmaceutical industry and medical organizationsIntern Med J352061015836497
- PapanikolaouGNBaltogianniMSContopoulos-IoannidisDG2001Reporting of conflicts of interest in guidelines of preventative and therapeutic interventionsBMC Med Res Methodol1311405896
- StreinerDLNormanGR1995Chapter 4: Scaling responsesHealth measurement scales: A practical guide to their development and use2nd edOxford, UKOxford University Press348
- TaylorRGilesJ2005Cash interests taint drug adviceNature4371070116237402
- WazanaA2000Physicians and the pharmaceutical industry. Is a gift ever just a gift?JAMA2833738010647801